Gene · 771
Papers1,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 1,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Down-Regulated ADH1C is Associated With Poor Prognosis in Colorectal Cancer Using Bioinformatics Analysis. | Front Mol Biosci | 2022 | 35300114 | PubTator, text mining | PubMed |
| A Metastatic Intrahepatic Cholangiocarcinoma With HPCs Features: Report of a Case. | Front Oncol | 2022 | 35299731 | PubTator, text mining | PubMed |
| Biomarkers for Breast Adenocarcinoma Using In Silico Approaches. | Evid Based Complement Alternat Med | 2022 | 35280505 | PubTator, text mining | PubMed |
| Longitudinal developmental trajectories do not follow cross-sectional age associations in hippocampal subfield and memory development. | Dev Cogn Neurosci | 2022 | 35278767 | PubTator, text mining | PubMed |
| An Update on Synthesis of Coumarin Sulfonamides as Enzyme Inhibitors and Anticancer Agents. | Molecules | 2022 | 35268704 | PubTator, text mining | PubMed |
| Cell-surface tethered promiscuous biotinylators enable comparative small-scale surface proteomic analysis of human extracellular vesicles and cells. | Elife | 2022 | 35257663 | PubTator, text mining | PubMed |
| Synthesis, Carbonic Anhydrase II/IX/XII Inhibition, DFT, and Molecular Docking Studies of Hydrazide-Sulfonamide Hybrids of 4-Methylsalicyl- and Acyl-Substituted Hydrazide. | Biomed Res Int | 2022 | 35252449 | PubTator, text mining | PubMed |
| Correlation between CA12 and TFF3 and their prediction value of neoadjuvant chemotherapy response in breast cancer. | J Clin Pharm Ther | 2022 | 35229335 | PubTator, text mining | PubMed |
| Retinal Transcriptomics Analysis Reveals the Underlying Mechanism of Disturbed Emmetropization Induced by Wavelength Defocus. | Curr Eye Res | 2022 | 35225751 | PubTator, text mining | PubMed |
| Congenital Bilateral Absence of the Vas Deferens. | Front Genet | 2022 | 35222530 | PubTator, text mining | PubMed |
| Discovery of Kinase and Carbonic Anhydrase Dual Inhibitors by Machine Learning Classification and Experiments. | Pharmaceuticals (Basel) | 2022 | 35215348 | PubTator, text mining | PubMed |
| Recent Advances in the Biological Activity of s-Triazine Core Compounds. | Pharmaceuticals (Basel) | 2022 | 35215333 | PubTator, text mining | PubMed |
| Nitroaromatic Hypoxia-Activated Prodrugs for Cancer Therapy. | Pharmaceuticals (Basel) | 2022 | 35215299 | PubTator, text mining | PubMed |
| Chloride Channels and Transporters: Roles beyond Classical Cellular Homeostatic pH or Ion Balance in Cancers. | Cancers (Basel) | 2022 | 35205604 | PubTator, text mining | PubMed |
| A framework for fibrolamellar carcinoma research and clinical trials. | Nat Rev Gastroenterol Hepatol | 2022 | 35190728 | PubTator, text mining | PubMed |
| Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors. | J Enzyme Inhib Med Chem | 2022 | 35188025 | PubTator, text mining | PubMed |
| Evaluating the detection ability of a range of epistasis detection methods on simulated data for pure and impure epistatic models. | PLoS One | 2022 | 35180244 | PubTator, text mining | PubMed |
| The effects of sulfated secondary bile acids on intestinal barrier function and immune response in an inflammatory in vitro human intestinal model. | Heliyon | 2022 | 35169646 | PubTator, text mining | PubMed |
| Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance. | Molecules | 2022 | 35163973 | PubTator, text mining | PubMed |
| NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase. | Int J Mol Sci | 2022 | 35163356 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/771/papers?page=22